Similar Items: Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
- Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region
- Corticosteroid Phobia in Patients with Atopic Dermatitis: A Narrative Review
- REVEAL AD ‐ Prevalence of Moderate and Severe Atopic Dermatitis in Ireland: A Cross‐ Sectional, Real World Study of a Secondary Care Population
- The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review
- Do Medication Beliefs Influence Adherence to Topical Therapies in Patients With Atopic Dermatitis?
- Corrigendum to “Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”